The Medical Letter on Drugs and Therapeutics
September 18, 1992
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
September 18, 1992 (Issue: 879)Loracarbef (Lorabid - Lilly), a new beta-lactam antibiotic with antimicrobial activity similar to the second-generation cephalosporins, has been approved by the US Food and Drug Administration for treatment of respiratory, skin, and urinary tract...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.